David Nutt
Impact in
- Clinical Psychology top 0.01%
- Psychedelics and Drug Studies
- Cellular and Molecular Neuroscience top 0.05%
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
Papers in
-
- Neurotransmitter Receptor Influence on Behavior 210
- Neuroscience and Neuropharmacology Research 154
-
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 147
- Co-authors
- Robin Lester Carhart-Harris (122 shared papers)David Erritzøe (80 shared papers)Leslie A. King (9 shared papers)Anne R. Lingford-Hughes (89 shared papers)Amanda Feilding (28 shared papers)Leor Roseman (46 shared papers)Lawrence D. Phillips (14 shared papers)Andrea L. Malizia (26 shared papers)
- Journals
- Journal of Psychopharmacology (172 papers)European Neuropsychopharmacology (58 papers)Psychopharmacology (57 papers)Neuropharmacology (33 papers)The British Journal of Psychiatry (28 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
David Nutt
1.1k papers receiving 56.8k citations
David Nutt's Hit Papers
Peers
Comparison fields: 5 of 219
- Clinical Psychology 17.7k
- Cellular and Molecular Neuroscience 9.9k
- Biological Psychiatry 748
- Behavioral Neuroscience 1.2k
- Pharmacology 5.9k
Countries citing papers authored by David Nutt
This map shows the geographic impact of David Nutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nutt more than expected).
Fields of papers citing papers by David Nutt
This network shows the impact of papers produced by David Nutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nutt. The network helps show where David Nutt may publish in the future.
Co-authors
The 25 scholars most cited alongside David Nutt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Hit paper breakdown → | 2006 | 1227 |
| 2 | Drug harms in the UK: a multicriteria decision analysis Hit paper breakdown → | 2010 | 1208 |
| 3 | Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study Hit paper breakdown → | 2016 | 1164 |
| 4 | Trial of Psilocybin versus Escitalopram for Depression Hit paper breakdown → | 2021 | 1013 |
| 5 | Development of a rational scale to assess the harm of drugs of potential misuse Hit paper breakdown → | 2007 | 923 |
| 6 | Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Hit paper breakdown → | 2012 | 861 |
| 7 | The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Hit paper breakdown → | 2014 | 823 |
| 8 | Psilocybin with psychological support for treatment-resistant depression: six-month follow-up Hit paper breakdown → | 2017 | 729 |
| 9 | Sleep disorders as core symptoms of depression Hit paper breakdown → | 2008 | 648 |
| 10 | Neural correlates of the LSD experience revealed by multimodal neuroimaging Hit paper breakdown → | 2016 | 623 |
| 11 | Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Hit paper breakdown → | 2018 | 607 |
| 12 | Serotonin and brain function: a tale of two receptors Hit paper breakdown → | 2017 | 539 |
| 13 | Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology Hit paper breakdown → | 2014 | 516 |
| 14 | British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders Hit paper breakdown → | 2010 | 515 |
| 15 | Homological scaffolds of brain functional networks Hit paper breakdown → | 2014 | 487 |
| 16 | 2005 | 486 | |
| 17 | The dopamine theory of addiction: 40 years of highs and lows Hit paper breakdown → | 2015 | 475 |
| 18 | 2006 | 447 | |
| 19 | Amphetamine, past and present – a pharmacological and clinical perspective Hit paper breakdown → | 2013 | 439 |
| 20 | Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms Hit paper breakdown → | 2017 | 436 |
About David Nutt
David Nutt is a scholar working on Cellular and Molecular Neuroscience, Experimental and Cognitive Psychology, Pharmacology, Clinical Psychology and Psychiatry and Mental health, having authored 1.1k papers that have together received 60.3k indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (210 papers), Psychedelics and Drug Studies (163 papers), Neuroscience and Neuropharmacology Research (154 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (147 papers), Treatment of Major Depression (120 papers), Substance Abuse Treatment and Outcomes (116 papers), Receptor Mechanisms and Signaling (62 papers) and Cannabis and Cannabinoid Research (46 papers). The work is most often cited by research in Clinical Psychology (17.7k citations), Cellular and Molecular Neuroscience (9.9k citations), Biological Psychiatry (748 citations), Behavioral Neuroscience (1.2k citations) and Pharmacology (5.9k citations). David Nutt has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Robin Lester Carhart-Harris, David Erritzøe, Leslie A. King, Anne R. Lingford-Hughes, Amanda Feilding, Leor Roseman, Lawrence D. Phillips, Andrea L. Malizia, Mendel Kaelen and Sue J. Wilson. Their work appears in journals such as Journal of Psychopharmacology, European Neuropsychopharmacology, Psychopharmacology, Neuropharmacology and The British Journal of Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.